NASDAQ:PALI

Palisade Bio Stock Forecast

etoro logo Buy PALI
*Your capital is at risk
$1.89
-0.0700 (-3.57%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of PALI AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PALI to Watchlist?
Some Reasons Why To Add PALI:
  • +147.2% price growth over the last year
  • Low bankruptcy risk (Altman Z-Score: 33.10)
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Palisade Bio, Inc. stock downgraded to Sell Candidate
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 13, 2026

The Palisade Bio, Inc. stock price fell by -3.57% on the last day (Monday, 13th Jul 2026) from $1.96 to $1.89. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 5.71% from a day low at $1.89 to a day high of $2.00. The price has fallen in 7 of the last 10 days. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -229 thousand shares and in total, 3 million shares were bought and sold for approximately $6.09 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.73% during the next 3 months and, with a 90% probability hold a price between $1.41 and $2.25 at the end of this 3-month period.

PALI Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 12.50%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Palisade Bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.01 and $1.92. A break-up above any of these levels will issue buy signals. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Palisade Bio, Inc. stock

Palisade Bio, Inc. finds support from accumulated volume at $1.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.108 between high and low, or 5.71%. For the last week, the stock has had daily average volatility of 8.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PALI) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Palisade Bio, Inc. to open at $1.93, and during the day (based on 14 day Average True Range), to move between $1.81 and $1.97, which gives a possible trading interval of +/-$0.165 (+/-9.11%) up or down from last closing price. If Palisade Bio, Inc. takes out the full calculated possible swing range there will be an estimated 9.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.81 (4.23%) than the resistance at $1.97 (4.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Palisade Bio, Inc. stock A Buy?

Palisade Bio, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.046 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $1.93 ( 1.90%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PALI Performance

Trading levels for PALI

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.03 7.62%
R2 1.99 5.44%
R1 1.97 4.09%
Price 1.89
S1 1.88 -0.278%
S2 1.86 -1.63%
S3 1.82 -3.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.34 23.81%
R2 2.08 10.05%
R1 1.97 4.23%
Price 1.89
S1 1.81 -4.23%
S2 1.80 -4.76%
S3 1.78 -5.82%

FAQ

What is the symbol for Palisade Bio, Inc. Stock and on which exchange is it traded?
The symbol for Palisade Bio, Inc. is PALI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Palisade Bio, Inc. Stock?
Palisade Bio, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Palisade Bio, Inc. Stock?
Palisade Bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Palisade Bio, Inc. Stock.

What's the current price of Palisade Bio, Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Palisade Bio, Inc. (PALI) share was $1.89.

What is the 52-week high and low for Palisade Bio, Inc. Stock?
The 52-week high for Palisade Bio, Inc. Stock is $2.86 and the 52-week low is $0.530.

What is the market capitalization of Palisade Bio, Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Palisade Bio, Inc. is 328.066M.

When is the next earnings date for Palisade Bio, Inc.?
The upcoming earnings date for Palisade Bio, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT PALISADE BIO, INC.
Palisade Bio
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during int...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE